Advanced Lung Adenocarcinoma (DBCOND0142726)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT06516887	Study of Bemcentinib Plus Pacritinib In Patients With Advanced Lung Adenocarcinoma	Bemcentinib Pacritinib	treatment	1 / 2	not_yet_recruiting
NCT05204758	Prophylactic TCM for Mitigation of EGFR-TKI Related Dermatological Adverse Effect	No drug interventions	prevention	3	completed
NCT05733000	CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors	Devimistat Fluorouracil Gemcitabine Hydroxychloroquine Lipoic acid	treatment	2	recruiting
NCT06495125	Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer	Avutometinib Defactinib Nivolumab	treatment	2	recruiting